| (Values in U.S. Thousands) | Mar, 2025 | Mar, 2024 | Mar, 2023 | Dec, 2025 | Dec, 2025 |
| Sales | 12,449,290 | 11,051,650 | 9,460,740 | 0 | 0 |
| Sales Growth | +12.65% | +16.82% | unch | unch | unch |
| Net Income | 1,951,990 | 1,385,040 | 807,990 | 0 | 0 |
| Net Income Growth | +40.93% | +71.42% | unch | unch | unch |
Daiichi Sankyo Ltd ADR (DSNKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Daiichi Sankyo Company Limited manufactures and sells pharmaceutical products principally in Japan, North America, Europe and internationally. Daiichi Sankyo Company Limited is based in Tokyo, Japan.
Fiscal Year End Date: 03/31